![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
UPDATE -- Encysive Pharmaceuticals Reports Fourth Quarter and Year End 2007 Financial Results
March 21, 2008 07:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, March 21, 2008 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) previously reported the filing of its annual report on Form 10-K for the year ended December 31, 2007. This...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Reports Fourth Quarter and Year End 2007 Financial Results
March 17, 2008 17:19 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, March 17, 2008 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced the filing of its annual report on Form 10-K for the year ended December 31, 2007. This filing...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Announces Date Change for Reporting 2007 Year-End Financials
February 22, 2008 07:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Feb. 22, 2008 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that the Company has changed the date for reporting its fourth quarter and year end 2007...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Launches THELIN (Sitaxentan Sodium) in Sweden
January 31, 2008 02:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Jan. 31, 2008 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets in Sweden....
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Launches THELIN (sitaxentan sodium) in Belgium and Luxembourg
January 14, 2008 02:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Jan. 14, 2008 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets in Belgium and...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Announces Patent Infringement Lawsuit Against Barr Laboratories
December 28, 2007 16:01 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 28, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that Mitsubishi Chemical Corporation, the patent holder for Argatroban injections, Mitsubishi...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Receives Delisting Warning Letter From NASDAQ
December 19, 2007 16:15 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 19, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) announced that today it received a delisting warning letter from the Nasdaq Stock Market, notifying it that the...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Provides THELIN Sales Guidance for 2007 and 2008
December 14, 2007 07:15 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 14, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced guidance for sales of THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets for 2007 and 2008....
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Launches Thelin (sitaxentan sodium) in Italy
November 26, 2007 02:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Nov. 26, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets in Italy for...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Announces Presentation of Sitaxsentan Data in Eisenmenger Syndrome At AHA Meeting
November 05, 2007 17:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Nov. 5, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals, Inc. (Nasdaq:ENCY) today announced that open label observational data from Columbia University suggests that sitaxsentan (THELIN), a...